- Home
- ITGR vs PCVX Comparison
ITGR vs PCVX Comparison
Compare ITGR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITGR
- PCVX
- Stock Information
- Founded
- ITGR 1970
- PCVX 2013
- Country
- ITGR United States
- PCVX United States
- Employees
- ITGR N/A
- PCVX N/A
- Industry
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- ITGR Health Care
- PCVX Health Care
- Exchange
- ITGR Nasdaq
- PCVX Nasdaq
- Market Cap
- ITGR 4.2B
- PCVX 4.4B
- IPO Year
- ITGR 2000
- PCVX 2020
- Fundamental
- Price
- ITGR $119.95
- PCVX $35.76
- Analyst Decision
- ITGR Strong Buy
- PCVX Strong Buy
- Analyst Count
- ITGR 10
- PCVX 10
- Target Price
- ITGR $145.90
- PCVX $136.50
- AVG Volume (30 Days)
- ITGR 450.1K
- PCVX 1.5M
- Earning Date
- ITGR 07-24-2025
- PCVX 08-05-2025
- Dividend Yield
- ITGR N/A
- PCVX N/A
- EPS Growth
- ITGR N/A
- PCVX N/A
- EPS
- ITGR 2.18
- PCVX N/A
- Revenue
- ITGR $1,746,192,000.00
- PCVX N/A
- Revenue This Year
- ITGR $11.03
- PCVX N/A
- Revenue Next Year
- ITGR $7.29
- PCVX N/A
- P/E Ratio
- ITGR $54.99
- PCVX N/A
- Revenue Growth
- ITGR 10.19
- PCVX N/A
- 52 Week Low
- ITGR $104.93
- PCVX $27.66
- 52 Week High
- ITGR $146.36
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- ITGR 49.25
- PCVX 57.77
- Support Level
- ITGR $116.25
- PCVX $31.79
- Resistance Level
- ITGR $122.99
- PCVX $36.89
- Average True Range (ATR)
- ITGR 2.44
- PCVX 1.51
- MACD
- ITGR -0.04
- PCVX 0.37
- Stochastic Oscillator
- ITGR 49.80
- PCVX 77.65
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.